Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1440, 2004-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drug therapy + standard treatment adds value in prostate cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 454, 2004-01 ,pp. :
Access to resources
Recommend
Where to now with hormonal therapy in prostate cancer?
Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. :
Is There a Growing Role for Endocrine Therapy in the Treatment of Breast Cancer?
By Lønning P.E.
Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. :
Oxaliplatin + fluorouracil the new standard in colorectal cancer?
Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. :
Do antiandrogens improve survival in prostate cancer?
Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. :